Provided by Tiger Trade Technology Pte. Ltd.

Keros Therapeutics, Inc.

11.08
+0.01000.09%
Volume:33.45K
Turnover:373.18K
Market Cap:219.69M
PE:-3.57
High:11.49
Open:11.07
Low:10.97
Close:11.07
52wk High:22.55
52wk Low:9.69
Shares:19.83M
Float Shares:18.25M
Volume Ratio:0.32
T/O Rate:0.18%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.1046
EPS(LYR):2.30
ROE:-17.16%
ROA:-11.78%
PB:0.84
PE(LYR):4.82

Loading ...

Aug 19, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 03, 2026

Major Issues Report

Form 8-K - Current report
Aug 03, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 03, 2026

Major Issues Report

Form 8-K - Current report
Jul 30, 2026

Major Issues Report

Form 8-K - Current report
Jul 30, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Jul 22, 2026

Major Issues Report

Form 8-K - Current report
Jul 17, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Jun 25, 2026

Major Issues Report

Form 8-K - Current report
Jun 12, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 04, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 04, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 04, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 03, 2026

Major Issues Report

Form 8-K - Current report
Jun 01, 2026

Major Issues Report

Form 8-K - Current report
May 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
May 14, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 14, 2026

Major Issues Report

Form 8-K - Current report
Apr 07, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Mar 31, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities